Purpose: Given the high burden of epilepsy on both health‐related quality of life (HRQoL)
and costs, identification of factors that are predictive of either reduced HRQoL or increased …

Background In this review we aimed to determine the economic impact of epilepsy and
factors associated with costs to individuals and health systems. Methods A narrative …

Purpose: Epilepsy causes a significant burden to patients and to society. We aimed to
calculate the factual excess in direct and indirect costs associated with epilepsy. Methods …

Objective To estimate long‐term socioeconomic consequences and health care costs of
epilepsy with onset in childhood and adolescence. Methods A historical prospective cohort …

The increasing number of treatment options and the high costs associated with epilepsy
have fostered the development of economic evaluations in epilepsy. It is important to …

Background A small group of people with epilepsy suffers from frequent seizures despite the
available pharmacological and non-pharmacological interventions. The impact of epilepsy …

Aims: To perform a systematic literature review of studies in peer reviewed journals on the
epidemiology, economics, and treatment patterns of epilepsy in selected countries in …

BACKGROUND: Patients suffering from epilepsy have an impaired health related quality of
life (HRQoL) because of seizures and treatment adverse events. Epilepsy affects differently …

Objectives Epilepsy is associated with a significant burden to patients and society. We
calculated the factual excess in direct and indirect costs associated with childhood-and …

2. Background CBZ was the product of serendipity during the development of imipramine [4],
hence having psychotropic properties akin to the antidepressants [5]. This does not suggest …